Seeking Alpha

Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping...

Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping Merck (MRK +1.2%) to Buy on optimism over its osteoporosis drug, and moving to Neutral on Bristol-Myers (BMY -0.9%) due to its limited total-return potential.
From other sites
Comments (1)
  • gdavidson99
    , contributor
    Comments (55) | Send Message
     
    That is good news...now if we can just get Merck to upgrade its rating of Bank of America to "Buy" everything would be peachy with me.
    4 Mar 2013, 10:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs